The first potent and selective inhibitors of the glycine transporter type 2.
Caulfield
W L
WL
Lead Discovery Unit, Organon Laboratories Ltd., Newhouse ML1 5SH, Scotland, UK.
Collie
I T
IT
Dickins
R S
RS
Epemolu
O
O
McGuire
R
R
Hill
D R
DR
McVey
G
G
Morphy
J R
JR
Rankovic
Z
Z
Sundaram
H
H
D026921:Amino Acid Transport Systems, Neutral; D000818:Animals; D001549:Benzamides / Q000138:chemical synthesis* / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D002352:Carrier Proteins / Q000037:antagonists & inhibitors*; D020650:Combinatorial Chemistry Techniques; D005998:Glycine / Q000378:metabolism*; D050487:Glycine Plasma Membrane Transport Proteins; D006801:Humans; D066298:In Vitro Techniques; D051379:Mice; D008862:Microsomes, Liver / Q000378:metabolism; D013329:Structure-Activity Relationship
C433813:4-benzyloxy-3,5-dimethoxy-N-((1-dimethylaminocyclopentyl)methyl)benzamide; D026921:Amino Acid Transport Systems, Neutral; D001549:Benzamides; D002352:Carrier Proteins; D050487:Glycine Plasma Membrane Transport Proteins; D005998:Glycine